权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Incorporating Learning Effects into Medical Device Active Safety Surveillance Methods

将学习效果纳入医疗器械主动安全监测方法

基本信息

批准号：
10352373
负责人：
MICHAEL E. MATHENY
金额：
$ 75.45万
依托单位：
VANDERBILT UNIVERSITY MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-02-01 至 2024-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10352373
关键词：
Achievement Acute Address Adverse event Algorithm Design Algorithms Blinded Blood Vessels Cardiovascular system Caring Characteristics Chronic Clinical Clinical Data Complex Data Data Aggregation Data Analytics Data Set Detection Development Device Designs Device Safety Devices Early Diagnosis Elements Environment Etiology Evaluation Event Feedback Generations Implant Injections Injury Institution Investigation Knowledge Lead Learning Literature Manufacturer Name Medical Device Medical Device Designs Medical Device Safety Methodology Methods Outcome Patient-Focused Outcomes Patients Performance Physicians Process Provider Public Health Publishing Registries Reporting Risk Safety Signal Transduction Specific qualifier value Statistical Models Structure Surveillance Methods Time Training United States Validation Variant adverse outcome algorithm development cardiovascular risk factor clinical heterogeneity design expectation experience high risk implantable device improved machine learning model novel open source patient population post-market prospective safety outcomes simulation surveillance strategy surveillance study systems research tool

项目摘要

Implantable medical devices have revolutionized contemporary cardiovascular care, and are used in a wide spectrum of acute and chronic cardiovascular conditions. However, medical device design fault or incorrect use may lead to significant risk of patient injury and represents an important preventable public health risk in the United States. To help identify device-related safety issues, a strategy of active, prospective, post-market safety surveillance has been recommended by the FDA, and evaluated methodologically. This type of surveillance offers significant advantages over traditional adverse event reporting strategies. However, all such approaches are challenged by the need to incorporate learning effects into expectations regarding safety. These learning impacts been repeatedly shown to have dramatic impacts on outcomes during early device experience. Quantifying learning effects on the outcomes associated with high-risk cardiovascular devices will improve our understanding of intrinsic device performance, thereby identifying patient populations best treated with such devices while simultaneously providing necessary feedback to device manufacturers to support iterative improvement in device design. Separately, understanding the impacts of learning may identify opportunities for targeted training as well as help to tease apart institutional and operator characteristics that may accelerate the achievement of optimal outcomes in the use of the specific cardiovascular device. This proposal seeks to extend the previously validated, open-source, active, prospective device safety surveillance tool, by developing and validating robust learning curve (LC) detection and quantification algorithms, designed to simultaneously account for the effects at the operator and institutional levels. We propose a “blinded” development strategy, in which one team will generate robust synthetic clinical data simulator with LC impacts, and the other team develops and applies LC detection and quantification algorithms, without knowledge of the underlying relationships, determine performance and accuracy through sequential refinement and validation steps. We propose to formally validate the optimized LC tools in real-world data through re-analysis of previously published LC effects on transcatheter valves and vascular closure devices using national cardiovascular registries. In addition, the LC tools will be incorporated into two active, prospective device safety surveillance studies of novel implantable cardiovascular devices using large clinical registries.

植入式医疗设备已经彻底改变了当代心血管护理，并且